Publication Name	World Journal of Gastroenterology
Manuscript ID	3923
Country	Japan

Received	2013-06-02 17:52
Peer-Review Started	2013-06-03 13:47
To Make the First Decision	2013-07-19 08:23
Return for Revision	2013-07-21 16:20
Revised	2013-08-02 14:48
Second Decision	2013-08-08 19:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-08-09 01:17
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-08-15 17:43
Typeset the Manuscript	2013-09-16 16:27
Publish the Manuscript Online	2013-10-18 17:02

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Toru Ishikawa
Funding Agency and Grant Number
Corresponding Author	Toru Ishikawa, MD, PhD, Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, 280-7 Teraji, Niigata 950-1104, Japan. toruishi@ngt.saiseikai.or.jp
Key Words	Hepatocellular carcinoma; Intrahepatic distant recurrence; Multicentric recurrence; Hepatitis C virus; Interferon; Arterial chemotherapy
Core Tip	Recent advances in treatment modalities have improved the survival rate of patients with hepatocellular carcinoma (HCC). However, long-term outcomes of patients with HCC remain unsatisfactory because of the high incidence of distant intrahepatic recurrence, multicentric recurrence and low survival rates. In particular, hepatitis C virus-related hepatocellular carcinoma has a much higher recurrence rate than other cancers. In this article, we describe the prognosis of recurrent HCC and the therapeutic strategies for reducing recurrent HCC.
Publish Date	2013-10-18 17:02
Citation	Ishikawa T. Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma. World J Gastroenterol 2013; 19(37): 6127-6130
URL	http://www.wjgnet.com/1007-9327/full/v19/i37/6127.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i37.6127

Full Article (PDF)	WJG-19-6127.pdf
Manuscript File	3923-Review.doc
Answering Reviewers	3923-Answering reviewers.pdf
Copyright License Agreement	3923-Copyright Assignment.pdf
Non-Native Speakers of English Editing Certificate	3923-Language certificate.pdf
Peer-review Report	3923-Peer review(s).pdf
Scientific Editor Work List	3923-Scientific editor work list.doc